Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl

FEBS Journal

Volumn 273, Issue 23, 2006, Pages 5442-5456

  Sanjay, Archana ^a,b   Miyazaki, Tsuyoshi ^a,c   Itzstein, Cecile ^a   Purev, Enkhtsetseg ^a   Horne, William C ^a   Baron, Roland ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone resorption; Cbl; Osteoclast; SH3; Src

Indexed keywords

CBL PROTEIN; GLUTAMIC ACID; GLYCINE; PHOSPHOTYROSINE; PROLINE; PROTEIN TYROSINE KINASE;

ARTICLE; BINDING SITE; ENZYME ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; OSTEOLYSIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY; STATISTICAL SIGNIFICANCE;

AMINO ACID MOTIFS; BINDING SITES; CELLS, CULTURED; MUTATION; OSTEOCLASTS; PEPTIDES; PHOSPHORYLATION; PROLINE; PROTO-ONCOGENE PROTEINS C-CBL; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS; UP-REGULATION;

EID: 33751099293     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05535.x     Document Type: Article

References (76)

1. Galisteo ML, Dikic I, Batzer AG, Langdon WY & Schlessinger J (1995) Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J Biol Chem 270, 20242-20245.
2. Lupher ML Jr, Reedquist KA, Miyake S, Langdon WY & Band H (1996) A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J Biol Chem 271, 24063-24068.
3. Bonita DP, Miyake S, Lupher ML, Langdon WY & Band H (1997) Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor a signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol Cell Biol 17, 4597-4610.
4. Thien CBF & Langdon WY (1997) EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene. Oncogene 14, 2239-2249.
5. Lupher ML, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B & Band H (1998) Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem 273, 35273-35281.
6. Meng W, Sawasdikosol S, Burakoff SJ & Eck MJ (1999) Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398, 84-90.
7. Sanjay A, Houghton A, Neff L, Didomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC et al. (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, avb3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152, 181-195.
8. Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A & Baron R (1999) Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem 274, 31707-31712.
9. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A et al. (1999) Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 4, 1029-1040.
10. Joazeiro CAP, Wing SS, Huang H-K, Leverson JD, Hunter T & Liu Y-C (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312.
11. Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y & Hirai H (1995) The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem 270, 10800-10805.
12. Tanaka S, Neff L, Baron R & Levy JB (1995) Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem 270, 14347-14351.
13. Fukazawa T, Miyake S, Band V & Band H (1996) Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J Biol Chem 271, 14554-14559.
14. cbl links c-Src and phosphatidylinositol 3¢-kinase to the integrin signaling pathway. J Biol Chem 272, 3780-3787.
15. Kowanetz K, Szymkiewicz I, Haglund K, Kowanetz M, Husnjak K, Taylor JD, Soubeyran P, Engstrom U, Ladbury JE & Dikic I (2003) Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J Biol Chem 278, 39735-39746.
16. Szymkiewicz I, Destaing O, Jurdic P & Dikic I (2004) SH3P2 in complex with Cbl and Src. FEBS Lett 565, 33-38.
17. de Jong R, ten Hoeve J, Heisterkamp N & Groffen J (1995) Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 270, 21468-21471.
18. Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE & Band H (1995) The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J Biol Chem 270, 19141-19150.
19. Andoniou CE, Thien CBF & Langdon WY (1996) The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene 12, 1981-1989.
20. Ribon V, Hubbell S, Herrera R & Saltiel AR (1996) The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol Cell Biol 16, 45-52.
21. cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J Biol Chem 271, 563-567.
22. Tsygankov AY, Mahajan S, Fincke JE & Bolen JB (1996) Specific association of tyrosine-phosphorylated c-Cbl with Fyn tyrosine kinase in T cells. J Biol Chem 271, 27130-27137.
23. Marengere LE, Mirtsos C, Kozieradzki I, Veillette A, Mak TW & Penninger JM (1997) Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J Immunol 159, 70-76.
24. Feshchenko EA, Langdon WY & Tsygankov AY (1998) Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J Biol Chem 273, 8323-8331.
25. Ueno H, Sasaki K, Honda H, Nakamoto T, Yamagata T, Miyagawa K, Mitani K, Yazaki Y & Hirai H (1998) c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3′-kinase pathway. Blood 91, 46-53.
26. Hunter S, Burton EA, Wu SC & Anderson SM (1999) Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem 274, 2097-2106.
27. Liu Y-C, Liu Y, Elly C, Yoshida H, Lipkowitz S & Altman A (1997) Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J Biol Chem 272, 9979-9985.
28. Hofmann K & Bucher P (1996) The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem Sci 21, 172-173.
29. Bartkiewicz M, Houghton A & Baron R (1999) Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J Biol Chem 274, 30887-30895.
30. Davies GC, Ettenberg SA, Coats AO, Mussante M, Ravichandran S, Collins J, Nau MM & Lipkowitz S (2004) Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene 23, 7104-7115.
31. Sanjay A, Horne WC & Baron R (2001) The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases. Sci STKE, doi: 10.1126/stke.2001.110. pe40.
32. Thien CBF & Langdon WY (2001) Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2, 294-305.
33. Dikic I & Giordano S (2003) Negative receptor signalling. Curr Opin Cell Biol 15, 128-135.
34. Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B & Yarden Y (1998) c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev 12, 3663-3674.
35. Miyake S, Lupher ML, Druker B & Band H (1998) The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor a. Proc Natl Acad Sci USA 95, 7927-7932.
36. Lee PSW, Wang Y, Dominguez MG, Yeung Y-G, Murphy MA, Bowtell DDL & Stanley ER (1999) The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J 18, 3616-3628.
37. Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N & Giordano S (2002) The endophilin-CIN85-Cbl complex mediates ligand-dependent down-regulation of c-Met. Nature 416, 187-190.
38. Andoniou CE, Lill NL, Thien CB, Lupher ML, Ota S, Bowtell DDL, Scaife RM, Langdon WY & Band H (2000) The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol Cell Biol 20, 851-867.
39. Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H & Baron R (2001) Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem 276, 31185-31193.
40. Howlett CJ & Robbins SM (2002) Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation. Oncogene 21, 1707-1716.
41. Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND & Band H (2002) Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci USA 99, 3794-3799.
42. Fang D, Wang H-Y, Fang N, Altman Y, Elly C & Liu Y-C (2001) Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J Biol Chem 276, 4872-4878.
43. Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY & Dikic I (2002) Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416, 183-187.
44. Szymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S & Dikic I (2002) CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J Biol Chem 277, 39666-39672.
45. Huang F & Sorkin A (2005) Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Mol Biol Cell 16, 1268-1281.
46. Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H & Choi Y (2001) A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (TRANCE) and CD40L-mediated akt activation. J Biol Chem 276, 30011-30017.
47. Scaife RM & Langdon WY (2000) c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology. J Cell Sci 113, 215-226.
48. Kirsch KH, Georgescu M-M, Shishido T, Langdon WY, Birge RB & Hanafusa H (2001) The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J Biol Chem 276, 4957-4963.
49. 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO J 17, 4391-4403.
50. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB & Baron R (1996) c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383, 528-531.
51. Bruzzaniti A, Neff L, Sanjay A, Horne WC, De Camilli P & Baron R (2005) Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol Biol Cell 16, 3301-3313.
52. Songyang Z & Cantley LC (1995) Recognition and specificity in protein tyrosine kinase-mediated signaling. Trends Biochem Sci 20, 470-475.
53. Deckert M, Elly C, Altman A & Liu Y-C (1998) Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J Biol Chem 273, 8867-8874.
54. Kassenbrock CK, Hunter S, Garl P, Johnson GL & Anderson SM (2002) Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem 277, 24967-24975.
55. Take H, Watanabe S & Takeda K, Yu ZX, Iwata N & Kajigaya S (2000) Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun 268, 321-328.
56. Ghosh AK, Reddi AL, Rao NL, Duan L, Band V & Band H (2004) Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase. J Biol Chem 279, 36132-36141.
57. Rao N, Ghosh AK, Pengcheng Z, Douillard P, Andoniou CE & Band H (2002) An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn. Signal Transduction 2, 29-39.
58. Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC & Baron R (2004) Src kinase activity is essential for osteoclast function. J Biol Chem 279, 17660-17666.
59. Feng S, Chen JK, Yu H, Simon JA & Schreiber SL (1994) Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247.
60. Lim WA, Richards FM & Fox RO (1994) Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372, 375-379.
61. Lim WA & Richards FM (1994) Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition. Nat Struct Biol 1, 221-225.
62. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW & Schreiber SL (1994) Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76, 933-945.
63. Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA & Kay BK (1996) Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCg, Crk, and Grb2. Proc Natl Acad Sci USA 93, 1540-1544.
64. Bowtell DDL & Langdon WY (1995) The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene 11, 1561-1567.
65. Xu W, Harrison SC & Eck MJ (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.
66. Horne WC, Sanjay A, Bruzzaniti A & Baron R (2005) The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev 208, 106-125.
67. Swaminathan G & Tsygankov AY (2006) The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol 209, 21-43.
68. Ota S, Hazeki K, Rao N, Lupher ML Jr, Andoniou CE, Druker B & Band H (2000) The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem 275, 414-422.
69. Chiusaroli R, Sanjay A, Henriksen K, Engsig MT, Horne WC, Gu H & Baron R (2003) Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev Biol 261, 537-547.
70. Ochoa G-C, Slepnev VI, Neff L, Ringstad N, Takei K, Daniell L, Kim W, Cao H, McNiven M, Baron R et al. (2000) A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol 150, 377-389.
71. Grossmann AH, Kolibaba KS, Willis SG, Corbin AS, Langdon WS, Deininger MWN & Druker BJ (2004) Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl. FEBS Lett 577, 555-562.
72. Thomas JW, Ellis B, Boerner RJ, Knight WB, White GC 2nd & Schaller MD (1998) SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem 273, 577-583.
73. Shishido T, Akagi T, Ouchi T, Georgescu M-M, Langdon WY & Hanafusa H (2000) The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci USA 97, 6439-6444.
74. Miyazaki T, Neff L, Tanaka S, Horne WC & Baron R (2003) Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol 160, 709-718.
75. He T-C, Zhou S, da Costa LT, Yu J, Kinzler KW & Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95, 2509-2514.
76. Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H et al. (2000) Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts. J Cell Biol 148, 333-342.